How to accelerate time-to-market with a hybrid cloud architecture
To reach their goal of transforming the Biopharma industry, AstraZeneca requested an architecture that could support streamlined data and analytics across ...
Typical R&D firms have gradually begun to realize that a robust Data Governance mechanism far outweighs the cost curtailing or controlling measures in short term. Regulatory environment under GxP has become ...
